ClinicalTrials.gg
RecruitingNCT07484555Updated Aug 27, 2026

Postural Rehabilitation for Visual Dysfunction in Forward Head Posture

An interventional study of motor control training and Sensor development training group in Forward Head Posture, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This assessor-blinded randomized controlled trial aims to compare the effects of motor control training, sensor-based biofeedback training using a wearable inertial measurement unit, and standardized postural correction exercises on mild visual dysfunction in university students with forward head posture. The trial seeks to establish whether targeted postural rehabilitation can produce measurable improvements in validated visual and sensorimotor outcomes.

Read the detailed description

Forward head posture is highly prevalent among young adults due to prolonged screen exposure and sustained cervical flexion. Emerging neurophysiological evidence suggests that cervical alignment influences visual stability through altered proprioceptive input, cervico-ocular reflex mechanisms, and sensorimotor integration. However, no randomized controlled trials have investigated whether correcting FHP leads to measurable improvements in validated visual parameters.

02

Conditions studied

  • Forward Head Posture

Browse trials for

Keywords

  • Balance
  • posture
  • Motor control training
  • Muscle endurance
  • Sensors
  • Visual impairment
03

In context

Vision Disorders

360 studies on the registry are indexed under Vision Disorders; 84 are open to participants now.

This study's planned enrollment of 72 is close to the median of 78 across 244 interventional studies indexed under Vision Disorders.

Browse Vision Disorders studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-30 years Both genders 17.5-27.99 CVA \<50° Mild visual impairment log Mar 0.1-0.5

Exclusion criteria

Exclusion Criteria:

    • Head and neck trauma or surgical history, Neurological disorders

      • Vestibular disorders, Benign paroxysmal positional vertigo (BPPV)
      • Congenital head and neck postural abnormality
      • Diagnosed oculomotor pathology (strabismus, nystagmus)
      • Diagnosed congenital ocular defects (corneal dystrophies)
      • Diagnosed glaucoma, cataract, uncorrected refractive errors
      • Diagnosed diabetes
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    motor control training group

    the motor control training is done in the stationary and in motion conditions with and without inertia and with and without object manipulations for the forward head posture participants.

    Other: motor control training

  • Experimental
    Sensor biofeedback training group

    Real time biofeedback training is being done through the sensor being applied to cervical spine during normal day activities.

    Device: Sensor development training group

  • Experimental
    conventional postural training

    this program consists on strengthening of deep cervical flexors and scapular retractors and stretching of cervical extensors and pectoralis major muscles

    Other: conventional posture training

  • No intervention
    control group

    postural education about proper ergonomics is being shared to the participants

Interventions

  • Othermotor control training

    the intervention will be a progressive training starting from the stationary, no inertia and no object manipulation to in motion with inertia and with object manipulation taking help of sitting standing and stepping stairs like activities keep the head in normal position with the help of a laser gun. the intervention duration is 45 minutes/day, with three sessions per week for 4 weeks.

  • DeviceSensor development training group

    the sensor will be being placed at cervical vertebrae C7 measuring current craniovertebral angle with the threshold being set at 50 degrees. the real time feedback will be shown on the mobile app. and the data will be recorded for whole intervention time. the intervention duration is 45 minutes/day, with three sessions per week for 4 weeks.

  • Otherconventional posture training

    the strengthening of deep neck flexors and retractors and stretching of pectoralis major and cervical extensors will be done using intervention duration is 45 minutes/day, with three sessions per week for 4 weeks.

06

What researchers measure

Primary outcomes

  1. visual impairment

    The mild visual impairment will be measured by LogMar chart. the smallest line that person can read will be recorded as reading of visual impairment. the score is generally in form of fractions.

    Time frame: baseline to 8th week

  2. oculomotor function

    this will be measured by the near point convergence test. the point at which blurring stated by participant will be measured in cms.

    Time frame: baseline to 8th week

  3. visual reaction time

    this will be measured on visual reaction time app on phone. the person has to click the screen when the stimulus arrives on screen. The average of 3 readings will be recorded as the visual reaction time

    Time frame: baseline to 8th week

  4. visual fatigue

    The visual fatigue will be measured by 17 item asthenopia questionnaire (ASQ-17). the score will be marked on 5 point likert scale with greater score shows more severity

    Time frame: baseline to 8th week

  5. craniovertebral angle (CVA)

    this will be measured by mobile app specified for said purpose. sideways picture will be taken and CVA will be noted from the app.

    Time frame: baseline to 8th week

Secondary outcomes

  1. flexor muscle endurance

    this will be measure by flexor endurance test as the end of couch in supine lying with head lift in chin tuck in position. the time of hold in seconds will be noted.

    Time frame: baseline to 8th week

  2. extensor muscle endurance

    the test will be done in prone lying holding the head in static position at the end of couch. the time of hold will be measured in seconds.

    Time frame: baseline to 8th weeks

  3. pelvic tilt

    the pelvic tilt will be measured by the pelvic inclinometer in degrees by place its both ends at anterior superior iliac spine.

    Time frame: baseline to 8th week

  4. static balance

    the static balance will be measured by Balance Error Scoring System test. the readings in double foot stance, single leg stance and tandem stance will be done on firm and foam surface and the composite score will be used. the no. of wrrors in adopting position will be marked as points. total score is 60. lower score indicate good balance.

    Time frame: baseline to 8th week

  5. dynamic balance

    The dynamic balance will be measured by the Y-balance test in anterior, postero-medial and postero-latertal positions. the composite score according to formula will be taken as final score. the higher score indicates good balance.

    Time frame: baseline to 8th week

07

Study locations

1 of 1 sites recruiting
  • Post-graduate research Lab, Riphah international university, gulberg greens campus, islamabad
    Islamabad, Capital 46000, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Nov 2026, 7 months after the start.

Of 84 non-industry interventional studies with no phase under Vision Disorders, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 51. This study's planned 7 months is below that.

Counting every sponsor, half of 94 studies reached it within 24 months; a quarter within 6 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 16, 2026
First posted
Mar 20, 2026
StartActual
Apr 1, 2026
Primary completionEst.
Nov 30, 2026
CompletionEst.
Feb 25, 2027
Last update
Aug 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07484555
Responsible party
Sponsor
First posted
Mar 20, 2026
Start date
Apr 1, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Feb 25, 2027 (estimated)
Last update
Aug 27, 2026

Study contacts

Qamar Mehmood, PHD
Contact
qamar.mehmood@riphah.edu.pk
03335151063
Qamar Mehmood, PHD
principal investigator · Riphah internatioal university

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion